Immunomodulation and Immunotherapy for Patients with Prostate Cancer: An Up-to-Date Review
Immunotherapy alone or in combination with chemotherapy or radiotherapy is the frontline treatment for melanoma and lung cancer. However, its role in prostate cancer is usually as a fourth-line treatment. It is usually employed in patients with metastasis, after androgen blockade and chemotherapy. T...
Saved in:
| Main Author: | Nigel P. Murray |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy Vaccines for Prostate Cancer Treatment
by: Jide He, et al.
Published: (2024-10-01) -
Current Update on Prostate Cancer Immunotherapy
by: Juliana E. Kim, et al.
Published: (2023-03-01) -
Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer
by: Karen A. Autio, et al.
Published: (2025-04-01) -
Research progress of tumor vaccines in the treatment of prostate cancer
by: Chen Zheng, et al.
Published: (2024-02-01) -
Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook
by: Wenhao Zhou, et al.
Published: (2024-12-01)